Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-016755
Filing Date
2026-05-13
Accepted
2026-05-13 16:35:46
Documents
47
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20260331_10q.htm   iXBRL 10-Q 812490
2 EXHIBIT 31.1 ex_909578.htm EX-31.1 16151
3 EXHIBIT 31.2 ex_909579.htm EX-31.2 14648
4 EXHIBIT 32.1 ex_909580.htm EX-32.1 8385
  Complete submission text file 0001437749-26-016755.txt   4696545

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20260331.xsd EX-101.SCH 40891
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20260331_cal.xml EX-101.CAL 16387
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20260331_def.xml EX-101.DEF 292035
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20260331_lab.xml EX-101.LAB 281242
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20260331_pre.xml EX-101.PRE 313022
51 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20260331_10q_htm.xml XML 638415
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 26974020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)